Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interventions for the Treatment of Persistent post‐COVID‐19 Olfactory Dysfunction." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431436/all/Adjuvant_treatment_of_anaplastic_oligodendrogliomas_and_oligoastrocytomas:_Cochrane_systematic_review. Accessed 04 October 2023.
Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431436/all/Adjuvant_treatment_of_anaplastic_oligodendrogliomas_and_oligoastrocytomas:_Cochrane_systematic_review. Accessed October 4, 2023.
Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431436/all/Adjuvant_treatment_of_anaplastic_oligodendrogliomas_and_oligoastrocytomas:_Cochrane_systematic_review
Interventions for the Treatment of Persistent post‐COVID‐19 Olfactory Dysfunction [Internet]. In: Cochrane Abstracts. [cited 2023 October 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431436/all/Adjuvant_treatment_of_anaplastic_oligodendrogliomas_and_oligoastrocytomas:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction
ID - 431436
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431436/all/Adjuvant_treatment_of_anaplastic_oligodendrogliomas_and_oligoastrocytomas:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -